BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25946031)

  • 1. Therapeutic Effectiveness of Screening for Multiple Endocrine Neoplasia Type 2A.
    Machens A; Dralle H
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2539-45. PubMed ID: 25946031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early, Prophylactic Thyroidectomy in Hereditary Medullary Thyroid Carcinoma: A 26-year Monoinstitutional Experience.
    Pelizzo MR; Torresan F; Boschin IM; Nacamulli D; Pennelli G; Barollo S; Rubello D; Mian C
    Am J Clin Oncol; 2015 Oct; 38(5):508-13. PubMed ID: 24064755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular epidemiology of multiple endocrine neoplasia 2: implications for RET screening in the new millenium.
    Machens A; Lorenz K; Sekulla C; Höppner W; Frank-Raue K; Raue F; Dralle H
    Eur J Endocrinol; 2013 Mar; 168(3):307-14. PubMed ID: 23211574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prophylactic thyroidectomy in children who are carriers of a multiple endocrine neoplasia type 2 mutation: description of 20 cases and recommendations based on the literature].
    de Groot JW; Links TP; Rouwe CW; van der Wal JE; Hofstra RM; Plukker JT
    Ned Tijdschr Geneeskd; 2006 Feb; 150(6):311-8. PubMed ID: 16503023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship.
    Yip L; Cote GJ; Shapiro SE; Ayers GD; Herzog CE; Sellin RV; Sherman SI; Gagel RF; Lee JE; Evans DB
    Arch Surg; 2003 Apr; 138(4):409-16; discussion 416. PubMed ID: 12686527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medullary thyroid carcinoma in multiple endocrine neoplasia types 2A and 2B.
    O'Riordain DS; O'Brien T; Weaver AL; Gharib H; Hay ID; Grant CS; van Heerden JA
    Surgery; 1994 Dec; 116(6):1017-23. PubMed ID: 7985081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic screening of patients with medullary thyroid cancer in a referral center in Greece during the past two decades.
    Sarika HL; Papathoma A; Garofalaki M; Saltiki K; Pappa T; Pazaitou-Panayiotou K; Anastasiou E; Alevizaki M
    Eur J Endocrinol; 2015 Apr; 172(4):501-9. PubMed ID: 25624014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Management of multiple endocrine neoplasia syndrome type 2 families in association with rare germline mutations of the RET proto-oncogene].
    Fitze G; Saeger HD; Roesner D; Schackert HK
    Klin Padiatr; 2004; 216(5):270-6. PubMed ID: 15455293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Profile of the RET A883F Germline Mutation: An International Collaborative Study.
    Mathiesen JS; Habra MA; Bassett JHD; Choudhury SM; Balasubramanian SP; Howlett TA; Robinson BG; Gimenez-Roqueplo AP; Castinetti F; Vestergaard P; Frank-Raue K
    J Clin Endocrinol Metab; 2017 Jun; 102(6):2069-2074. PubMed ID: 28323957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mutations of ret-proto-oncogene in thyroid medullary carcinoma].
    Frank-Raue K; Höppner W; Buhr H; Herfarth C; Ziegler R; Raue F
    Dtsch Med Wochenschr; 1997 Feb; 122(6):143-9. PubMed ID: 9081799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations.
    Learoyd DL; Gosnell J; Elston MS; Saurine TJ; Richardson AL; Delbridge LW; Aglen JV; Robinson BG
    Clin Endocrinol (Oxf); 2005 Dec; 63(6):636-41. PubMed ID: 16343097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of multiple endocrine neoplasia type 2A in children: therapeutic results of early thyroidectomy and prognostic value of codon analysis.
    Szinnai G; Meier C; Komminoth P; Zumsteg UW
    Pediatrics; 2003 Feb; 111(2):E132-9. PubMed ID: 12563086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center.
    Elisei R; Romei C; Cosci B; Agate L; Bottici V; Molinaro E; Sculli M; Miccoli P; Basolo F; Grasso L; Pacini F; Pinchera A
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4725-9. PubMed ID: 17895320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial medullary carcinoma prevention, risk evaluation, and RET in children of families with MEN2.
    Moore SW; Appfelstaedt J; Zaahl MG
    J Pediatr Surg; 2007 Feb; 42(2):326-32. PubMed ID: 17270543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do the recent American Thyroid Association (ATA) Guidelines accurately guide the timing of prophylactic thyroidectomy in MEN2A?
    Grubbs EG; Waguespack SG; Rich TA; Xing Y; Ying AK; Evans DB; Lee JE; Perrier ND
    Surgery; 2010 Dec; 148(6):1302-9; discussion 1309-10. PubMed ID: 21134565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MEN 2A family--prophylactic thyroidectomy for asymptomatic siblings with positive 634 codon mutation.
    Agarwal S; Agarwal A; Chand G; Gupta SK; Jain M; Ramakant P
    J Assoc Physicians India; 2012 Feb; 60():127-9. PubMed ID: 22715565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peak incidence of pheochromocytoma and primary hyperparathyroidism in multiple endocrine neoplasia 2: need for age-adjusted biochemical screening.
    Machens A; Lorenz K; Dralle H
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E336-45. PubMed ID: 23284010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic thyroidectomy in pediatric carriers of multiple endocrine neoplasia type 2A or familial medullary thyroid carcinoma: mutation in C620 is associated with Hirschsprung's disease.
    Bütter A; Gagné J; Al-Jazaeri A; Emran MA; Deal C; St-Vil D
    J Pediatr Surg; 2007 Jan; 42(1):203-6. PubMed ID: 17208566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence by age and predictors of medullary thyroid cancer in patients with lower risk germline RET proto-oncogene mutations.
    Rich TA; Feng L; Busaidy N; Cote GJ; Gagel RF; Hu M; Jimenez C; Lee JE; Perrier N; Sherman SI; Waguespack SG; Ying A; Grubbs E
    Thyroid; 2014 Jul; 24(7):1096-106. PubMed ID: 24617864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical spectrum of RET proto-oncogene mutations in codon 790.
    Bihan H; Murat A; Fysekidis M; Al-Salameh A; Schwartz C; Baudin E; Thieblot P; Borson-Chazot F; Guillausseau PJ; Cardot-Bauters C; Raingeard I; Requeda E; Sadoul JL; Reznik Y;
    Eur J Endocrinol; 2013 Sep; 169(3):271-6. PubMed ID: 23756355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.